Circle Neurovascular Imaging

Calgary, Alberta, Canada  All Canada companies → Founded Circle Neurovascular Imaging was created as an expansion of Circle Cardiovascular Imaging, which was founded in 2007.
Imaging AI Specialist Specialty-Focused AI
Emergency Medicine Neurology Radiology
Neurology AI Radiology & Imaging AI Triage & ER/ICU AI
Series B (for parent company, Circle Cardiovascular Imaging) — $19.9M (for parent company, Circle Cardiovascular Imaging)

Products

StrokeSENS LVO
Circle Neurovascular Imaging
Neurology AI
StrokeSENS LVO is an AI-powered software for automated detection and notification of suspected Large Vessel Occlusions (LVOs) on CT Angiography (CTA) images, supporting early engagement of the stroke team.

See all 1 product →

About Circle Neurovascular Imaging

Circle Neurovascular Imaging (Circle NVI) is a healthcare AI company dedicated to revolutionizing stroke diagnosis and treatment. Leveraging AI-assisted advanced technology, their flagship product, StrokeSENS, empowers frontline healthcare clinicians to more rapidly identify strokes and make swift, accurate decisions regarding patient care. This clinically validated technology has received clearances from Health Canada and the FDA, and the company has partnered with GE Healthcare for its implementation across health systems.

StrokeSENS is designed to provide automated detection and notification of suspected anterior circulation large-vessel occlusions (LVOs) on contrast-enhanced CT angiography exams. Furthermore, the algorithm can analyze noncontrast-enhanced CT exams to offer automated Alberta Stroke Program Early CT Scoring (ASPECTS) assessment for regions with suspected acute ischemic tissue. This technology significantly supports quick identification, accurate image interpretation, effective patient transport decisions, and assists healthcare professionals, particularly in remote and rural areas where specialized expertise may be limited. Circle NVI operates as a subsidiary of Circle Cardiovascular Imaging, a recognized leader in cardiac imaging solutions.

Focus Areas

Stroke diagnosis and treatment AI-assisted neurovascular imaging large vessel occlusion (LVO) detection ASPECTS assessment multi-phase CTA perfusion

Business Intelligence

Key InvestorsUCeed Health Fund (for Circle NVI); Thoma Bravo, BDC, Kayne Anderson Capital Advisors, Yaletown Partners, Accelerate Fund, Epic Capital Management Inc., Innovate Calgary, Composition Capital (for parent company Circle Cardiovascular Imaging)
PartnershipsGE Healthcare, Aidoc
AcquisitionsNone (for Circle NVI); Circle Cardiovascular Imaging acquired Corstem Inc.
TechnologyAI-assisted advanced technology, software that takes imaging directly from CT scanners, automated detection and notification, DICOM-compliant software system, machine learning algorithms, vendor-agnostic integration, real-time notifications and advanced visualizations
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Stroke Diagnosis & Treatment
Specializes in AI-assisted neurovascular imaging for acute stroke, focusing on rapid and accurate diagnosis to improve patient outcomes. Their StrokeSENS software is designed to transform stroke care by enabling quicker identification and more informed treatment decisions.
AI-Assisted Neurovascular Imaging
Leverages artificial intelligence to provide automated detection and notification of critical stroke indicators, augmenting image analysis and supporting communication across stroke teams.
Large Vessel Occlusion (LVO) Detection
Offers AI-based software (StrokeSENS LVO) for automated detection and notification of suspected anterior circulation large-vessel occlusions on contrast-enhanced CT angiography (CTA) exams, facilitating the review of time-sensitive cases.
ASPECTS Assessment
Provides automated Alberta Stroke Program Early CT Scoring (ASPECTS) assessment on non-contrast enhanced CT (NCCT) exams, helping to easily identify early ischemic changes and standardize the assessment of acute ischemic tissue.
Multi-Phase CTA Perfusion
Utilizes StrokeSENS mCTA Perfusion to visualize and assess perfusion abnormalities and estimate brain tissue perfusion from routine multi-phase CTA acquisitions, offering an alternative to traditional CT Perfusion with similar predictive ability for final infarction.
Key Differentiators
AI-powered, clinically validated software (StrokeSENS) with rapid processing times (10-60 seconds), improved diagnostic accuracy (sensitivity, specificity, inter-reader agreement for ASPECTS), vendor-agnostic integration, real-time mobile notifications, and a focus on streamlining clinical workflows.
Technology Stack
AI-based imaging software (StrokeSENS, part of the cvi42 platform) that processes NCCT and CTA images (DICOM format), outputs perfusion heatmaps and occlusion alerts (DICOM), and integrates seamlessly with PACS, AI marketplaces, or as a stand-alone application, with local or virtualized deployment options.
Physician Tip

For physicians, Circle Neurovascular Imaging's StrokeSENS platform stands out by enabling significantly faster and more accurate decision-making in acute stroke cases, where every second counts. The AI-powered LVO detection and automated ASPECTS scoring reduce subjectivity and standardize evaluations, leading to more consistent and reliable diagnoses. Its seamless integration into existing workflows and real-time mobile notifications streamline the stroke care pathway, reducing clerical burden and improving patient throughput. Furthermore, the ability to provide advanced stroke assessment from routine CT/CTA, even when CTP or MRI is unavailable, makes it a valuable tool for front-line clinicians, especially in remote or underserved areas. The clinically validated nature of the technology provides confidence in its diagnostic capabilities.

Circle Neurovascular Imaging's StrokeSENS is designed to be vendor-agnostic and seamlessly integrates into existing radiological environments, including PACS. It supports integration via AI marketplaces or distribution platforms and can be deployed locally on dedicated hardware or virtualized environments (VM, Docker). This flexibility ensures compatibility with various hospital IT infrastructures and workflows, minimizing disruption upon adoption. The output, including perfusion heatmaps and occlusion alerts, is provided in DICOM format for easy incorporation into existing systems.

Products by Circle Neurovascular Imaging

1 product in the directory

StrokeSENS LVO
Circle Neurovascular Imaging
Neurology AI
StrokeSENS LVO is an AI-powered software for automated detection and notification of suspected Large Vessel Occlusions (LVOs) on CT Angiography (CTA) images, supporting early engagement of the stroke team.

What the Web Says

Circle Neurovascular Imaging, also known as Circle NVI, appears to be a company focused on medical imaging analysis, particularly for neurovascular conditions. While specific product reviews are scarce on major platforms like G2 and Capterra, the company's work seems to involve advanced imaging techniques. Employer reviews, primarily from Glassdoor, suggest a mixed but generally positive work environment with a focus on innovation and employee well-being, though some challenges related to growth and management communication have been noted.

Overall: Mixed

Strengths

  • Innovative technology in neurovascular imaging
  • Positive work culture and employee focus (Glassdoor)
  • Opportunities for professional growth (Glassdoor)
  • Good benefits package (Glassdoor)
  • Collaborative team environment (Glassdoor)
  • Impactful work in healthcare

Limitations

  • Limited public product reviews on major platforms (G2, Capterra)
  • Potential for rapid growth challenges impacting structure (Glassdoor)
  • Some concerns about management communication or clarity (Glassdoor)
  • Specific product details and user experiences are not widely available
  • Lack of presence on some common software review sites
  • Information on specific pricing or implementation is not readily found

Based on reviews from: Glassdoor, G2 (searched, limited results), Capterra (searched, limited results), Reddit (searched, limited relevant results), Healthcare IT review sites (searched, limited specific reviews)

Last updated: 2026-07-17

Videos

News, demos, and interviews about Circle Neurovascular Imaging.

Loading videos...

Videos load interactively. If none appear, search YouTube for Circle Neurovascular Imaging →

View all on YouTube

Press & Coverage

GE HealthCare
WorldStrokeDay: GE Healthcare & Circle Neurovascular Imaging Announce A New Collaboration To Enhance Acute Stroke Care with AI
GE Healthcare and Circle Neurovascular Imaging (Circle NVI) announced a collaboration to integrate Circle NVI's AI-powered solutions, such as StrokeSENS LVO software, into GE Healthcare's FastStroke processing platform to enhance acute stroke care. This partnership aims to provide clinicians with advanced tools for faster and more accurate diagnosis and triage of acute stroke patients.
2021-10
University of Calgary
Circle Neurovascular Imaging - University of Calgary
Circle Neurovascular Imaging (Circle NVI) is transforming stroke diagnosis and treatment with its AI-assisted StrokeSENS technology, which has received Health Canada and FDA clearance. The company, founded by University of Calgary researchers, also secured investment from the UCeed Health Fund to support its growth and market entry.
unknown
accessdata.fda.gov
Circle Neurovascular Imaging, Inc Kyle Mayr October 21, 2021 Official Correspondent Circle Cardiovascular Imaging, Inc. 800 - accessdata.fda.gov
The FDA issued a 510(k) premarket notification for Circle Neurovascular Imaging's StrokeSENS LVO, a radiological computer-aided triage and notification software. This device is intended to assist clinicians in identifying suspected Large Vessel Occlusion (LVO) in head CTA images for workflow triage.
2021-10
Thoma Bravo
Circle Cardiovascular Imaging Announces Strategic Growth Investment from Thoma Bravo
Circle Cardiovascular Imaging Inc. (Circle CVI), the parent company of Circle Neurovascular Imaging, announced a strategic growth investment from Thoma Bravo, a leading software investment firm. This investment aims to drive future growth, product innovation, and strengthen Circle CVI's market leadership in cardiovascular imaging solutions.
2022-03
Thoma Bravo
Circle Cardiovascular Imaging Announces Leadership Transition - Thoma Bravo
Circle Cardiovascular Imaging announced Erkan Akyuz as the new Chief Executive Officer, succeeding co-founder Greg Ogrodnick, effective August 5, 2024. This leadership transition occurs during a period of accelerated growth and product innovation for the company, which has expanded its global footprint and launched its next-generation platform, cvi42 6.1.
2024-07
AuntMinnie
Circle CVI gets U.S. FDA clearance for AI software - AuntMinnie
Circle Cardiovascular Imaging (Circle CVI) received FDA clearance for cvi42 | Plaque, an AI software for plaque analysis on coronary CT angiography (CCTA). This software integrates into existing CT workflows, offering clinicians improved data control, faster processing, and enhanced workflow efficiency.
2025-10
NeuroNews
Aidoc announces strategic partnerships with Cercare Medical and Circle CVI - NeuroNews
Aidoc announced strategic partnerships with Cercare Medical and Circle Cardiovascular Imaging (CVI) to expand its neurosciences portfolio with advanced MR perfusion and automated ASPECTS. These collaborations aim to connect fragmented neuro workflows and accelerate high-stakes decisions for stroke and complex neurological conditions.
2025-12
GlobeNewswire
Circle Cardiovascular Imaging Expands cvi42 Platform with Advanced Vascular CT Capabilities - GlobeNewswire
Circle Cardiovascular Imaging (Circle CVI) expanded its cvi42 platform to include advanced Vascular CT analysis, integrating Astute Imaging's AI-driven technology. This enhancement allows for comprehensive cardiovascular workflows, enabling cardiac, vascular, and structural heart analysis within a single platform.
2026-03

Frequently Asked Questions

Circle Neurovascular Imaging's flagship product for stroke diagnosis is StrokeSens, an AI-powered software designed to assist frontline healthcare clinicians. It provides automated detection and notification of suspected anterior circulation large vessel occlusions (LVOs) on contrast-enhanced CT angiography (CTA) exams and performs automated Alberta Stroke Program Early CT Scoring (ASPECTS) assessment on noncontrast-enhanced CT exams.
For LVO detection, StrokeSens has demonstrated a mean sensitivity of 89.4% and a mean specificity of 87.4% on CTA images. The AI-powered ASPECTS assessment enhances reader performance, showing improved sensitivity (+9.7%), specificity (+1.6%), and inter-reader agreement (+28%) in diagnostic studies.
While multi-phase CTA is recognized for its benefits in acute stroke imaging, StrokeSens primarily focuses on LVO detection on CTA and ASPECTS assessment on non-contrast CT. However, StrokeSens does provide processing tools that generate parametric maps related to tissue characteristics like ischemia and blood flow, which can be relevant to perfusion analysis.
Circle Neurovascular Imaging's StrokeSens has received FDA clearance (for LVO detection only in the U.S.), Health Canada clearance, and Therapeutic Goods Administration (TGA) clearance in Australia, as well as availability in the EU and U.K. The parent company, Circle Cardiovascular Imaging Inc., maintains ISO 13485:2016 and MDSAP certificates, aligning its quality system with global medical device regulations including EU MDR and U.S. FDA QMSR (21 CFR Part 820).
Circle Neurovascular Imaging offers flexible pricing models, including both one-time license fees and subscription-based options, which can be based on the number of analyses or installations. The company is known for its strong customer support, with a focus on continuous improvements and innovation, and provides technical support to its users.
Circle Neurovascular Imaging has a significant partnership with GE Healthcare for the implementation of its technology across health systems. Additionally, they have partnered with Aidoc to integrate their AI-powered ASPECTS scoring into Aidoc's Full Brain Solution, enhancing stroke care in Europe.
Circle Neurovascular Imaging is a subsidiary of Circle Cardiovascular Imaging, a Canadian-based company founded in 2007 that is a global leader in medical imaging software. The parent company has raised $19.9 million across four funding rounds from investors like Thoma Bravo, indicating strong investor confidence and a solid financial foundation.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.